IL22 and irritable bowel syndrome: Additionally, abnormal toll-like receptor expression and dendritic cell activation in both the gut and skin further exacerbate inflammation in IBD and psoriasis, with cytokines like IL-17, IL-22, and IL-12 playing distinct roles in these diseases [43,46].